What's New

Last Posted: Mar 19, 2019

• Bridging the Gap Between Direct-to-Consumer Testing and Medical-Grade Genetic Testing-- he One-Stop Solution Will Allow Direct-to-Consumer Kit Users to Confirm Their Hereditary Cancer ResultsT
  PRB web, March 18, 2019
• CRISPR/Cas9 – An evolving biological tool kit for cancer biology and oncology
  X Tian et al, NPJ Precision Oncology, March 18, 2019
• March 22nd is National Lynch Syndrome Awareness Day!
  CDC, 2019
• A 44-gene set constructed for predicting the prognosis of clear cell renal cell carcinoma.
  Wang Yonggang et al. International journal of molecular medicine 2018 Dec 42(6) 3105-3114
• A gene expression signature of Retinoblastoma loss-of-function predicts resistance to neoadjuvant chemotherapy in ER-positive/HER2-positive breast cancer patients.
  Risi Emanuela et al. Breast cancer research and treatment 2018 Jul 170(2) 329-341
• A hedgehog pathway-dependent gene signature is associated with poor clinical outcomes in Luminal A breast cancer.
  Rudolph M et al. Breast cancer research and treatment 2018 Jun 169(3) 457-467
• Adjuvant versus neoadjuvant chemotherapy in triple-negative breast cancer patients with BRCA mutations.
  Clifton Katherine et al. Breast cancer research and treatment 2018 Jul 170(1) 101-109
• BRCA mutations and their influence on pathological complete response and prognosis in a clinical cohort of neoadjuvantly treated breast cancer patients.
  Wunderle Marius et al. Breast cancer research and treatment 2018 Aug 171(1) 85-94
• Circulating microRNAs from the miR-106a-363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer.
  Li Minghui et al. Breast cancer research and treatment 2018 Jul 170(2) 257-270
• Clinical Application of Circulating Tumor DNA in the Genetic Analysis of Patients with Advanced GIST.
  Xu Hao et al. Molecular cancer therapeutics 2018 17(1) 290-296
• Distinctive psychological and social experiences of women choosing prophylactic oophorectomy for cancer prevention.
  Meadows Rachel et al. Health care for women international 2018 39(5) 595-616
• Distress, uncertainty, and positive experiences associated with receiving information on personal genomic risk of melanoma.
  Smit Amelia K et al. European journal of human genetics : EJHG 2018 26(8) 1094-1100
• FDA Approval of PARP Inhibitors and the Impact on Genetic Counseling and Genetic Testing Practices.
  Buchtel Kathryn M et al. Journal of genetic counseling 2018 27(1) 131-139
• Germline mutations in lung cancer and personalized medicine.
  Cetta Francesco et al. Familial cancer 2018 17(3) 429-430
• Mining Public Databases for Precision Oncology.
  Roszik Jason et al. Trends in cancer 2018 4(7) 463-465